KRAS & TP53 mutations cause malignant mesothelioma
Anthi Krontira (Patras, Greece)
Source: ERS Lung Science Conference 2017
Disease area: Thoracic oncology
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: